{
  "id": "mhgap#risk_safety_ae60781a",
  "content": "83\nMental Health Gap Action Programme (mhGAP) guideline for mental, neurological and substance use disorders\ny A specialist should periodically review whether y ASM polytherapy is, in general, associated with\nsodium valproate is the most suitable treatment higher risks of congenital malformations than\nfor all women of childbearing potential taking ASM monotherapy.\nsodium valproate.\nEPI5. Which interventions are effective in preventing epilepsy-related\nmortality, including sudden unexpected death of someone with\nepilepsy (SUDEP)?\nRecommendation (new): Nocturnal supervision should be considered for prevention of sudden\nunexpected death in epilepsy (SUDEP).\nStrength of recommendation: Conditional\nCertainty of evidence: Very low\nJustification evidence of a seizure, excluding documented status\ny Evidence was extracted from one systematic review: epilepticus and in whom postmortem examination\nMaguire et al., 2020 (1 case–control study) (186). does not reveal a structural or toxicological cause for\ndeath.\ny Very low-certainty evidence suggests that\nsupervision at night reduces the incidence of SUDEP y This intervention is considered especially\n(OR = 0.34; 95% CI: 0.22 to 0.53). appropriate for those who have convulsive seizures\nfrom sleep.\ny SUDEP has a reported incidence of 1.2–1.3 per\n1000 person-years and represents one of the y Nocturnal supervision was defined by Langan",
  "metadata": {
    "source": "WHO mhGAP-IG 2023",
    "url": "https://www.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "sleep",
      "study",
      "risk_safety",
      "referral",
      "management"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General — Risk Safety 83\nMental Health Gap Action Programme (mhGAP) guideline for mental, neurological and substance use disorders\ny A specialist should periodically review whether y ASM polytherapy is, in general, associated with\nsodium valproate is the most suitable treatment higher risks of congenital malformations than\nfor all women of childbearing potential taking ASM monotherapy.\nsodium valproate.\nEPI5. Which interventions are effective in preventing epilepsy-related\nmortality, including sudden unexpected death of someone with\nepilepsy (SUDEP)?\nRecommendation (new): Nocturnal supervision should be considered for prevention of sudden\nunexpected death in epilepsy (SUDEP).\nStrength of recommendation: Conditional\nCertainty of evidence: Very low\nJustification evidence of a seizure, excluding documented status\ny Evidence was extracted from one systematic review: epilepticus and in whom postmortem examination\nMaguire et al., 2020 (1 case–control study) (186). does not reveal a structural or toxicological cause for\ndeath.\ny Very low-certainty evidence suggests that\nsupervision at night reduces the incidence of SUDEP y This intervention is considered especially\n(OR = 0.34; 95% CI: 0.22 to 0.53). appropriate for those who have convulsive seizures\nfrom sleep.\ny SUDEP has a reported incidence of 1.2–1.3 per\n1000 person-years and represents one of the y Nocturnal supervision was defined by Langan 83\nmental health gap action programme (mhgap) guideline for mental, neurological and substance use disorders\ny a specialist should periodically review whether y asm polytherapy is, in general, associated with\nsodium valp..."
}